The New York Stem Cell Foundation (NYSCF) is a global leader in accelerating the development of treatments and cures through cutting-edge stem cell science. At the heart of their work is a one-of-a-kind automated laboratory that empowers researchers to scale discoveries with unprecedented precision. The Salah Foundation’s investment is helping NYSCF expand its AI-powered data infrastructure, unlocking faster insights and advancing personalized medicine for diseases once thought untreatable.
“The New York Stem Cell Foundation Research Institute remains deeply grateful for the Salah Foundation’s visionary partnership to empower stem cell researchers with unique AI and automation technologies. The Foundation’s crucial investment to expand our data analysis infrastructure will enable our global network of researchers to gain unprecedented insights from NYSCF’s treasure trove of data made from the cells of hopeful patients. Leveraging new AI tools, we will bring better treatments and cures to patients with greater speed and precision than ever before.“
